Experimental Therapies: New treatments for hepatitis B including pre-clinical development that have not yet been studied in humans, and various drugs that are in phase I, II and III development.

General

· 459. Complementary and Alternative Medicine Use in Children with Chronic Viral Hepatitis (Updated Nov 1)

· 821. Surface Antigen Seroconversion after Allogenic Hematopoietic Stem Cell Transplantation in Patient with Chronic Hepatitis B Virus Infection

· 823. Efficacy of Hepatitis B Vaccine Against Antiviral Drug-resistant Hepatitis B Virus Mutants in the Chimpanzee Model

· 824. New Insights into HBV Pathogenesis from Kinetic Analysis of HBeAg Titre Decay During Potent Antiviral Therapy.

· 826. CD4+LAP+ Regulatory T Cells Mediate the Enhancement of the Anti-HBV Immune Response: A novel method for an adjuvant-dependent augmentation of anti-viral immunity

· 875. Treatment of Chronic Viral Hepatitis in Woodchucks by Prolonged Intrahepatic Expression of Interleukin-12

· 877. Drug-resistant and Wild-type Strains of HBV Are Inhibited Equally by Simvastatin

· 879. Efficacy of RNAi Constructs for Inhibiting Hepatitis B Virus Replication Has Implications for Antiviral Cell and Gene Therapy

· 949. Serine Palmitoyltransferase Inhibitor Suppresses Hepatitis B Virus Replication